- Drugging of RNA via antisense oligonucleotides (ASOs) and small molecules
- Efficacy limitations on the efficiency of ASO binding
- Biologically silent binding small molecule-mRNA have been conjugated with an RNase activator to degrade the RNA motif and negate its bioactivity